Unilabs Middle East, a leading provider of diagnostic services internationally, has introduced Hologic “Genius Digital Diagnostics System” to enhance cervical cancer laboratory services in UAE, making it the first country in the Middle East to take advantage of this new technology.

This next-generation system is the first in digital cytology to leverage the value of deep learning-based artificial intelligence (AI) and sophisticated volumetric imaging technology.

The Genius Digital Diagnostics System is intended to revolutionize the detection and diagnosis of cervical cancer by accurately identifying pre-cancerous lesions and cancerous cells in women with a high degree of precision.

The system changes the workflow from slide to screen, resulting in truly unprecedented efficiency, collaboration, and diagnostic insights to improve patient care while securing, storing, and reviewing cases remotely and streamlining analysis for clinicians.

Dr. Ali Bayoumi Medical Director, Unilabs Middle East Cluster, and Medical Director, Unilabs Global SBU Genetics & Pharma, stated: “We are excited to launch such an innovative technology, the first of its kind in the Middle East, in partnership with Cytomed, the authorized agent for Genius Digital Diagnostics in the UAE. This move reflects Unilabs’ steadfast commitment to adopting the latest medical innovations to enhance the quality of healthcare.”